These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. Farge T; Saland E; de Toni F; Aroua N; Hosseini M; Perry R; Bosc C; Sugita M; Stuani L; Fraisse M; Scotland S; Larrue C; Boutzen H; Féliu V; Nicolau-Travers ML; Cassant-Sourdy S; Broin N; David M; Serhan N; Sarry A; Tavitian S; Kaoma T; Vallar L; Iacovoni J; Linares LK; Montersino C; Castellano R; Griessinger E; Collette Y; Duchamp O; Barreira Y; Hirsch P; Palama T; Gales L; Delhommeau F; Garmy-Susini BH; Portais JC; Vergez F; Selak M; Danet-Desnoyers G; Carroll M; Récher C; Sarry JE Cancer Discov; 2017 Jul; 7(7):716-735. PubMed ID: 28416471 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication. Hansen Q; Bachas C; Smit L; Cloos J Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375 [TBL] [Abstract][Full Text] [Related]
9. Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML. Wang JD; Xu JQ; Long ZJ; Weng JY Clin Transl Oncol; 2023 Jun; 25(6):1805-1820. PubMed ID: 36899123 [TBL] [Abstract][Full Text] [Related]
10. Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy Resistance in Acute Myeloid Leukemia. Boët E; Sarry JE Cancer Res; 2024 Apr; 84(7):950-952. PubMed ID: 38558131 [TBL] [Abstract][Full Text] [Related]
11. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Pollyea DA; Stevens BM; Jones CL; Winters A; Pei S; Minhajuddin M; D'Alessandro A; Culp-Hill R; Riemondy KA; Gillen AE; Hesselberth JR; Abbott D; Schatz D; Gutman JA; Purev E; Smith C; Jordan CT Nat Med; 2018 Dec; 24(12):1859-1866. PubMed ID: 30420752 [TBL] [Abstract][Full Text] [Related]
12. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism. Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889 [TBL] [Abstract][Full Text] [Related]
14. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation. Amaya ML; Inguva A; Pei S; Jones C; Krug A; Ye H; Minhajuddin M; Winters A; Furtek SL; Gamboni F; Stevens B; D'Alessandro A; Pollyea DA; Reigan P; Jordan CT Blood; 2022 Jan; 139(4):584-596. PubMed ID: 34525179 [TBL] [Abstract][Full Text] [Related]
15. Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy. Chen Y; Liang Y; Luo X; Hu Q Cell Death Dis; 2020 Apr; 11(4):291. PubMed ID: 32341354 [TBL] [Abstract][Full Text] [Related]
16. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities. Marchand T; Pinho S Front Immunol; 2021; 12():775128. PubMed ID: 34721441 [TBL] [Abstract][Full Text] [Related]